Pharma & Biotech - Page 11

The Section 232 pharmaceutical tariff regime is no longer a looming threat for the industry — it is now active law following the July 31, 2026, deadline. President Trump’s April 2, 2026,

A potential merger between AstraZeneca and Bristol Myers Squibb has been circulating on Wall Street, and the numbers involved are staggering. The Financial Times reported that the two pharmaceutical giants have held

Sanofi’s new chief executive Belén Garijo has spoken publicly for the first time about her plans to turn around the French pharmaceutical giant’s recent run of clinical disappointments. Garijo outlined a strategic

Viatris has received a formal rebuke from the US Food and Drug Administration over a direct-to-consumer video that allegedly misled viewers about the use of a cystic fibrosis inhaler. The FDA sent

Eli Lilly and contract manufacturer Resilience have committed $750 million to significantly expand production of Lilly’s KwikPen injectable device across its diabetes and obesity medicine portfolio. The investment will fund major upgrades

Four Democratic senators are demanding answers from Health and Human Services Secretary Robert F. Kennedy Jr. over potential conflicts of interest tied to a recent Merck settlement. Merck & Co. (MRK) agreed

Amgen (AMGN) has teamed up with YouTube megastar MrBeast to raise awareness and funding for pediatric cancer research through a high-profile video campaign. The collaboration was featured in MrBeast’s video titled “I

Sanofi (SNY) chief executive Belén Garijo has used her first earnings call as CEO to lay out an ambitious vision for reversing the French pharmaceutical giant’s recent fortunes. Garijo, who previously led

Chip Parkinson, CEO of Gifthealth, says specialty medicine represents the clearest opportunity for direct-to-patient models to prove their value at scale. Specialty drugs already account for more than half of all drug

Legend Biotech has confirmed that chief executive Ying Huang, Ph.D., has stepped down after six years leading the company. Alan Bash, who has served as president of Carvykti since 2024, will take